Notably, previous studies indicated that SPARCL‐1 mutations are associated with an increased risk of autism spectrum disorder (Taketomi et al. 2022), providing another piece of evidence that its regulation impacts the normal functioning of synapses. Here, SPARCL1 is linked to autism spectrum disorder.